Results 101 to 110 of about 12,790 (219)
血小板麻酔 : ヒヒ体外循環中の可逆的血小板機能抑制の研究 [PDF]
, 1997 Thesis (Ph. D. in Medical Sciences)--University of Tsukuba, (B), no.
Hiramatsu Yuji, 平松 祐司
core
Bivalirudin started during emergency transport for primary PCI. [PDF]
, 2013 BACKGROUND: Bivalirudin, as compared with heparin and glycoprotein IIb/IIIa inhibitors, has been shown to reduce rates of bleeding and death in patients undergoing primary percutaneous coronary intervention (PCI).
Berg, J. van den +25 more
core +1 more source
Gene mutations of platelet glycoproteins and response to tirofiban in acute coronary syndrome
São Paulo Medical JournalCONTEXT AND OBJECTIVES: Glycoprotein inhibitors (abciximab, eptifibatide and tirofiban) are used in patients with unstable angina and non-ST-segment elevation myocardial infarction before percutaneous coronary intervention.
Antonio de Padua Mansur +5 more
doaj +1 more source
Drug-Eluting Stents in Primary Angioplasty Long-Term Clinical Outcomes [PDF]
, 2007 INTRODUCTION: The use of drug-eluting stents in the context of mechanical reperfusion following ST-segment elevation myocardial infarction (MI) was initially viewed with concern. The main fear was that the drugs' action in unstable lesions could increase
Bernardes, L +8 more
core
Novel strategies for assessing platelet reactivity [PDF]
, 2016 There are many approaches to assessing platelet reactivity and many uses for such measurements. Initially, measurements were based on the ability of platelets separated from other blood cells to aggregate together following activation with an appropriate
Dovlatova N +10 more
core +2 more sources
Revista Colombiana de Cardiología, 2015 Introducción: Los inhibidores de glicoproteína IIb/IIIa reducen los eventos cardiovasculares mayores adversos (MACE) en pacientes con síndrome coronario agudo.
Julián Ochoa +5 more
doaj +1 more source
Platelet Glycoprotein IIb/IIIa Receptor Inhibition in Non-ST-Elevation Acute Coronary Syndromes [PDF]
, 1999 BACKGROUND: Glycoprotein (GP) IIb/IIIa receptor blockers prevent life-threatening cardiac complications in patients with acute coronary syndromes without ST-segment elevation and protect against thrombotic complications associated ...
Akkerhuis, K.M. (Martijn) +5 more
core
e0635 The evaluation to the efficacy and safety of tirofiban in acute coronary syndrome patients with clopidogrel resistance during percutaneous coronary intervention [PDF]
, 2010 F. Xianghua +9 more
openalex +1 more source
Acute Coronary Syndromes: Management and Secondary Prevention [PDF]
, 2018 Acute coronary syndromes represent a broad spectrum of ischemic myocardial events including unstable angina, non-ST elevation myocardial infarction and acute ST elevation myocardial infarction, which are associated with high morbidity and mortality. They
Wenaweser, Peter, Windecker, Stephan
core